Nextrove
Dr. Ujwala Salvi is a Founder & Chief Executive Officer, at NUCLEON Therapeutics LLP which is a Mumbai based CRO leading in Clinical trial operation, CDM and end to end Pharmacovigilance. Their esteemed client involves MNC Indian Pharma companies and Tier II pharma companies from U.S.
Dr. Salvi has worked in large global operations, managed strategic relationships, and played a key role in winning new business, setting up off-shored partnerships and in identifying new BU service lines and growing existing ones. Her areas of expertise include Pharmacovigilance, Clinical Trial operations, Clinical Data Management and feasibilities of new drug development and Analytics.
She is an MBA in Finance from Indian Institute of Management (IIM), Kolkata & Doctorate in Applied Biology from Mumbai University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Nextrove
Nextrove, LLC. a global lifesciences system integrator focused exclusively on serving Pharmaceutical, Biotech and Clinical Research organizations. We take pride in being a premier yet nimble system integrator assisting our clients in Drug Safety & Pharmacovigilance, Oracle Argus Safety Hosting, Medical Information Call Center (MICC), Veeva Vault, Salesforce, Commercial Excellence, Enterprise Quality Management System (EQMS), RIM, PV and Clinical Operations Outsourcing and Medical Affairs. Our mission is to deliver preeminent and innovative solutions that enable the global Health Science industry to improve public and patient safety. With a global footprint including US, Japan, China, Canada, Milan and India and domain experts having an average experience of over 18 years, we have helped our clients meet project timelines, effectiveness and cost targets in a variety of engagements. Nextrove Lifesciences Solutions portfolio includes Progressive NEXT, Progressive Compliance, Progressive CONVEY, Progressive MICC, GRRACE and ClinConnect.